(November 30, 2018, 1:07 PM EST) -- SILVER SPRING, Md. — The Food and Drug Administration on Nov. 29 warned that some multiple sclerosis patients taking Lemtrada brand alemtuzumab have experienced rare strokes or tears in arteries leading to the head and neck....